Mutations in GBA2 Cause Autosomal-Recessive Cerebellar Ataxia with Spasticity

HAMMER, MONIA B.; ELEUCH-FAYACHE, GHADA; SCHOTTLAENDER, LUCIA V.; NEHDI, HOUDA; GIBBS, J. RAPHAEL; AREPALLI, SAMPATH K.; CHONG, SEAN B.; HERNANDEZ, DENA G.; SAILER, ANNA; LIU, GUOXIANG; MISTRY, PRAMOD K.; CAI, HUAIBIN; SHRADER, GINAMARIE; SASSI, CELESTE; BOUHLAL, YOSR; HOULDEN, HENRY; HENTATI, FAYÇAL; AMOURI, RIM; SINGLETON, ANDREW B.

AMERICAN JOURNAL OF HUMAN GENETICS

CELL PRESS

Lugar: United States; Año: 2013 vol. 92 p. 245 - 251

0002-9297

Autosomal-recessive cerebellar ataxia (ARCA) comprises a large and heterogeneous group of neurodegenerative disorders with more than 20 different forms currently recognized, many of which are also associated with increased tone and some of which have limb spasticity. Gaucher disease is a lysosomal storage disease resulting from a defect in the enzyme acid β-glucosidase 1. β-glucosidase 2 is an enzyme with similar glucosylceramidase activity but to date has not been associated with a monogenic disorder. We studied four unrelated consanguineous families of Tunisian decent diagnosed with cerebellar ataxia of unknown origin. We performed homozygosity mapping and whole-exome sequencing in an attempt to identify the genetic origin of their disorder. We were able to identify mutations responsible for autosomal-recessive ataxia in these families within the gene encoding β-glucosidase 2, GBA2. Two nonsense mutations (c.363C>A [p.Tyr121(∗)] and c.1018C>T [p.Arg340(∗)]) and a substitution (c.2618G>A [p.Arg873His]) were identified, probably resulting in nonfunctional enzyme. This study suggests GBA2 mutations are a cause of recessive spastic ataxia and responsible for a form of glucosylceramide storage disease in humans.